Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

75%

3 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
3(100.0%)
3Total
Phase 4(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT01558531Suspended

Drug Eluting Balloon in Peripheral Intervention for In-Stent Restenosis

Role: lead

NCT01556542Phase 4Completed

Drug Eluting Balloon in peripherAl inTErvention SFA

Role: lead

NCT01558505Phase 4Completed

Drug Eluting Balloon in peripherAl inTErvention For Below The Knee Angioplasty Evaluation

Role: lead

NCT01637896Phase 4Terminated

A Comparison Between Paclitaxel-eluting Balloon in Combination With BMS Implantation vs Conventional Balloon and DES Implantation

Role: lead

All 4 trials loaded